These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24616922)

  • 1. Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer.
    Kim HS; Chang YG; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Lee EK; Park S; Ahn YM; Park WS; Lee JY; Nam SW
    FEBS J; 2014 Feb; 281(3):851-61. PubMed ID: 24616922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT.
    Noh JH; Bae HJ; Eun JW; Shen Q; Park SJ; Kim HS; Nam B; Shin WC; Lee EK; Lee K; Jang JJ; Park WS; Lee JY; Nam SW
    Cancer Res; 2014 Mar; 74(6):1728-38. PubMed ID: 24448241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
    Noh JH; Chang YG; Kim MG; Jung KH; Kim JK; Bae HJ; Eun JW; Shen Q; Kim SJ; Kwon SH; Park WS; Lee JY; Nam SW
    Cancer Lett; 2013 Jul; 335(2):455-62. PubMed ID: 23499894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins.
    Noh JH; Jung KH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park WS; Lee JY; Nam SW
    PLoS One; 2011; 6(11):e28103. PubMed ID: 22132221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of 1,25(OH)2D3 on the proliferation of hepatocellular carcinoma cells through the downregulation of HDAC2.
    Huang J; Yang G; Huang Y; Zhang S
    Oncol Rep; 2017 Sep; 38(3):1845-1850. PubMed ID: 28737824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of protein kinase CK2alpha on the proliferation and invasion of human nasopharyngeal carcinoma].
    Liu L; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):529-31. PubMed ID: 20021963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.
    Zheng B; Han M; Shu YN; Li YJ; Miao SB; Zhang XH; Shi HJ; Zhang T; Wen JK
    Cell Res; 2011 Oct; 21(10):1487-508. PubMed ID: 21383775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
    J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
    Das N; Datta N; Chatterjee U; Ghosh MK
    Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B.
    Wang M; Liao J; Wang J; Xu M; Cheng Y; Wei L; Huang A
    Cell Death Dis; 2024 Aug; 15(8):593. PubMed ID: 39147759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25(OH)
    Huang J; Yang G; Huang Y; Zhang S
    Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 13. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats.
    Salama YA; El-Karef A; El Gayyar AM; Abdel-Rahman N
    Life Sci; 2019 Nov; 236():116933. PubMed ID: 31614146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells.
    Zhang H; Zhao B; Huang C; Meng XM; Bian EB; Li J
    PLoS One; 2014; 9(5):e95520. PubMed ID: 24788349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
    Lim WC; Kim H; Ko H
    J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
    Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
    Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt activation by Ca
    Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
    J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin.
    Li L; Mei DT; Zeng Y
    Biomed Pharmacother; 2016 Dec; 84():284-290. PubMed ID: 27665474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.